News

Inhaled Corticosteroids may lower the Chance of COVID-19 Infection in Asthmatic Children

Aug, 2021 - By WMR

Inhaled Corticosteroids may lower the Chance of COVID-19 Infection in Asthmatic Children

A team of researchers from Duke University studied the COVID-19 infection in children with asthma in the age group ranging from 5 years to 17 years.

The COVID-19 pandemic has caused unprecedented challenge to the global public health and continues to spread globally despite vaccination efforts. According to the World Health Organization’s report, approximately 194 million confirmed cases of COVID-19 including 4 million deaths were reported globally as of July 25, 2021. It is to be noted here that the prevalence of cardiovascular diseases, respiratory diseases, and other diseases such as hypertension, diabetes are high risk factors for COVID-19. The researchers conducted a cohort study of 49,455 children who received health care in Durham County, North Carolina from March 1, 2020 to October 31, 2020. Out of 49,455 children, 6,515 had asthma. The researchers noted that 1.1% of children were COVID positive and out of this only 66 children had asthma during the study period. They examined how the presence of comorbid atopic diseases and the use of inhaled corticosteroids (ICS) can modify the relation between asthma and risk of COVID-19 infection. They found that asthma was related to lower risk of COVID-19 infection among children who were prescribed ICS or had comorbid atopic diseases. More importantly, they observed that children with asthma did not require hospitalization after acquiring SARS-CoV-2 infection. This is a relief to healthcare providers and parents of asthmatic children as during the study no evidence was found that support asthma predisposes children to severe COVID-19.

The researchers recommended the use of these medications during this COVID-19 pandemic as the data shows that these medications do not increase vulnerability to COVID-19 infection. On the contrary, this study demonstrates that the use of ICS may decrease the rate of COVID-19 infection among children.

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2021 Worldwide Market Reports. All rights reserved